FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | |||
|
||||
Member
|
The FDA met on June 10 regarding the approval of Ginlenia, the first oral pill for MS. The advisory board voted 25-0 to recommend approval. The FDA usually follows this board's advice when giving the final green light. They have postponed sale of it for 3 more months until September to think about safety measures since the drug is a new entity. It looks like we may have these pills by fall.
These articles have very useful information. http://m.industry.bnet.com/pharma/10...-drug-gilenia/ http://cenblog.org/the-haystack/2010...e-green-light/ http://www.webmd.com/multiple-sclero...t-oral-ms-drug
__________________
On Tysabri and love it. . |
|||
![]() |
![]() |
|
|
![]() |
||||
Thread | Forum | |||
Novartis had changed the name of Fingolimod to Gilenia (aka FTY720). | Multiple Sclerosis | |||
would like more information | Reflex Sympathetic Dystrophy (RSD and CRPS) | |||
FTY720/Fingolimod | Multiple Sclerosis | |||
Fingolimod/FTY720 Research from ECTRIMS | Multiple Sclerosis |